Published in Transpl Immunol on June 18, 2004
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int (2012) 2.47
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 2.29
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol (2005) 2.23
Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2012) 2.10
Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol (2010) 2.03
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med (2002) 1.83
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
The Th17-defining transcription factor RORγt promotes glomerulonephritis. J Am Soc Nephrol (2010) 1.67
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.66
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J Am Soc Nephrol (2009) 1.62
Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol (2009) 1.55
Microbiologic follow-up study in adult bronchiectasis. Respir Med (2007) 1.52
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol (2006) 1.49
Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis. J Am Soc Nephrol (2012) 1.49
T cells in crescentic glomerulonephritis. J Am Soc Nephrol (2006) 1.45
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant (2004) 1.42
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant (2011) 1.23
Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.22
T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2008) 1.20
IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment. J Am Soc Nephrol (2005) 1.20
Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.19
Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int (2005) 1.18
Epidemiology of diabetic nephropathy. Contrib Nephrol (2011) 1.18
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. J Am Soc Nephrol (2004) 1.14
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol (2007) 1.13
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology (Carlton) (2009) 1.12
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med (2006) 1.10
Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol (2007) 1.10
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol (2003) 1.08
Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol (2004) 1.06
Outcome in adult bronchiectasis. COPD (2005) 1.06
Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) (2007) 1.04
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum (2011) 1.03
IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant (2009) 1.03
IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. J Immunol (2002) 1.02
Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis. J Am Soc Nephrol (2003) 1.02
The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol (2011) 1.02
Endogenous foxp3(+) T-regulatory cells suppress anti-glomerular basement membrane nephritis. Kidney Int (2011) 1.01
T cells in glomerulonephritis. Springer Semin Immunopathol (2003) 1.01
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol (2004) 1.00
Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol (2004) 1.00
The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring) (2007) 0.99
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int (2003) 0.99
A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int (2007) 0.98
Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun (2008) 0.98
Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial Transplant (2005) 0.97
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol (2002) 0.97
Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol (2002) 0.97
Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs (2006) 0.97
The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol (2002) 0.96
Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int (2010) 0.96
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int (2003) 0.96
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis. Proc Natl Acad Sci U S A (2012) 0.96
Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant (2003) 0.96
Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol (2011) 0.96
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int (2003) 0.95
p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol (2004) 0.95
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol (2005) 0.95
A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.95
Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.94
Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function. Blood (2013) 0.94
An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity. J Immunol (2004) 0.94
CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms. Kidney Int (2005) 0.94
CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J Immunol (2006) 0.93
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
Phenotypes of adult bronchiectasis: onset of productive cough in childhood and adulthood. COPD (2009) 0.92
Endogenous Tim-1 (Kim-1) promotes T-cell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int (2011) 0.91
Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis. J Am Soc Nephrol (2005) 0.90
Diabetic kidney disease: act now or pay later. Acta Diabetol (2010) 0.90
The isolation and purification of biologically active recombinant and native autoantigens for the study of autoimmune disease. J Immunol Methods (2005) 0.90
Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. Am J Pathol (2010) 0.90
The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN. J Am Soc Nephrol (2013) 0.89
Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells. J Am Soc Nephrol (2008) 0.89
Macrophage-mediated renal injury is dependent on signaling via the JNK pathway. J Am Soc Nephrol (2004) 0.89